Clarivate

CLVT on NYSE. Clarivate sells data and analytics tools to researchers, businesses, and universities. Market value $1.5bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to September 2026. Some use the latest annual report instead, as marked. Quality checks use five annual reports, the latest for the year to December 2025.

Recent profit includes a big one-time charge, so we price the company excluding that charge.

Should I look at this?

Not a fit for our list right now

See Technology stocks that passed both tests

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to September 2026
25.1%very high

For every $100 of what the whole company costs, it produced $25.06 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
annual report to December 2025
72.8×full

You pay 72.8 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
-2.3%five-year median

Each dollar kept in the business earns -2 cents a year. Above 10 is good.

Quality score: 60 of 100. Price score: 33 of 100. Our list needs 70 on quality and 60 on price.

$2.01 a share, 42% above its 1-year low

Over the past year the price has ranged from $1.42 to $3.87.

Pays no dividend

Prices from Friday’s close (20 November).

Five years of cash, in billions

0.2
0.3
0.5
0.4
0.4
0.3
2021202220232024202512 monthsto Sep '26
Revenue
$1.9bn$2.7bn$2.6bn$2.6bn$2.5bn
Operating margin
-4.6%-147.6%-27.9%-10.8%2.9%
Debt to equity
0.470.730.790.880.91
Shares outstanding
0.67bn0.66bn0.71bn0.66bn0.64bn

Health checks

  • Free cash flow positive5 of 5 years
  • Accounting looks honest (Beneish)Nothing unusual
  • Financial strength (Piotroski)5 of 9
  • Profit backed by cash (accruals)Yes
  • Debt0.91× equity
  • Revenue growth, five yearsStrong, 14.4% a year
  • Buying back its own sharesYes, 5% fewer since 2021

The quarter to September 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $482 million last quarter, down 9% on a year ago.
  • A loss of $81 million, compared with a loss of $28 million a year ago.
  • Spare cash over the past 12 months: $322 million, down from $335 million.
  • 4% fewer shares than a year ago. Each share owns a bit more of the company.
  • Debt is $3.9 billion more than cash, down from $4.2 billion a year ago.
  • Sales grew on a year ago in 1 of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
December 2024$663m
March 2025$594m
June 2025$621m
September 2025$530m
December 2025$909m
March 2026$586m
June 2026$587m
September 2026$482m
Profit by quarter
Profit by quarter
Quarter toAmount
December 2024-$192m
March 2025-$104m
June 2025-$72m
September 2025-$28m
December 2025$3m
March 2026-$40m
June 2026-$269m
September 2026-$81m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
24 February 2026
Next quarterly (estimated, 10-Q)
2 February 2027

Who owns it

4 long-term investors we follow own it, down from 5 last quarter. 242 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

2 investors own more than 5%; 1 of them is pushing for change.

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 1 insider bought $2m of shares on the open market. 2 sold $7m, $1m of it under preset trading plans.

  • Veinstein Bar
    President, A&G
    Sold
    Date
    18 November 2026
    Shares
    254,558
    Price
    $2.13
    Value
    $542,209
  • Cornick Kenneth L.
    Director
    Bought
    Date
    7 August 2026
    Shares
    250,000
    Price
    $1.85
    Value
    $462,500
  • Cornick Kenneth L.
    Director
    Bought
    Date
    6 August 2026
    Shares
    650,000
    Price
    $1.86
    Value
    $1m
  • Snyder Andrew Miles
    Director
    Sold
    Date
    3 August 2026
    Shares
    2,489,618
    Price
    $1.94
    Value
    $5m
  • Veinstein Bar
    President, A&G
    Sold
    under a preset trading plan
    Date
    1 December 2025
    Shares
    309,902
    Price
    $3.74
    Value
    $1m

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 24 Feb 2026, plus the 10-Q filed 3 Nov 2026 and 16 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

  • It isn't cheap on profits: 72.8× operating profit.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.